|5:01 PM EDT||
Tammy Baldwin, D-WI 2nd
Ms. BALDWIN. Madam Speaker, I yield myself such time as I may consume.
Madam Speaker, I rise in strong support of H. Con. Res. 182, recognizing the need to pursue research into the causes, treatment and eventual cure for idiopathic pulmonary fibrosis, IPF, supporting the goals and ideals of National Idiopathic Pulmonary Fibrosis Week, and for other purposes.
IPF is a debilitating and generally fatal disease which afflicts more than 128,000 Americans, with more than 48,000 new cases diagnosed each year. IPF is often undiagnosed or misdiagnosed and is a disease marked by progressive scarring of the lungs, causing an irreversible loss of the lung tissue's ability to transport oxygen.
The legislation before us today recognizes the need to pursue research into the causes of IPF. H. Con. Res. 182 expresses support for the work of advocates and organizations in educating, supporting and providing hope for individuals who suffer from the disease and supports the designation of National Idiopathic Pulmonary Fibrosis Awareness Week.
This is an important piece of legislation, and I would like to commend my colleague and friend Mr. Deal for all of his hard work on this issue. I urge my colleagues to join me in support of this resolution.
Madam Speaker, I reserve the balance of my time.